Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Regular NSAID use linked to erectile dysfunction

By News team

Regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with erectile dysfunction (ED), researchers have suggested.

An analysis of data for over 80,000 men in the US aged between 45 and 62 years revealed that ED is more prevalent in those exposed to NSAIDs than in those who had not regularly taken the drugs (see Panel).

After adjusting for comorbidities such as diabetes, hypertension and a history of smoking, regular NSAID use was associated with a 22 per cent increase in ED risk. The risk increase was similar across the age range.

The researchers say their findings raise the question of the role inflammation and cyclo-oxygenase pathways have in causing ED.

Cyclo-oxygenase enzymes are involved in the production of prostaglandins, which might be vital for penile erection — meaning that the inhibition of cyclo-oxygenase by NSAIDs could contribute to ED, they explain.

They add that alternative explanations are possible, such as NSAID use being related to underlying problems that are the direct cause of the ED, and suggest further studies are needed to elucidate the relationship between NSAID use and ED.

“However, if this is a direct relationship, the current strategy of using NSAIDs for cardiovascular disease protection as well as other common uses of NSAIDs should be weighed against the potential side effects of ED,” they advise.

The study is due to be published in the April issue of The Journal of Urology (2011,185:1388).

Paul Wright, specialist cardiac pharmacist at Barts and The London NHS Trust, said he has not come across the link much in practice, but pointed out that cardiovascular disease (CVD) is known to increase the risk of ED due to endothelial dysfunction.

"The [study’s] definition of NSAID use is too broad — it included low-dose aspirin and paracetamol — and as such will select patients with CVD," he said, explaining that a high proportion of CVD patients will be taking aspirin 75mg daily.

"Although the final analysis had adjusted for most of these variables, it is very difficult to draw conclusions," he said. He suggested that further analysis of NSAID use excluding low-dose aspirin and paracetamol may yield different results and be better applied to practice.

Study method and results

Researchers analysed data collected in an earlier men’s health study for 80,966 US men.

Information on erectile function and NSAID use was self-reported via a questionnaire, with additional data on NSAID exposure obtained from pharmacy and electronic health records.

Men were defined as exposed to NSAIDs if they had: received more than a 100-day supply in total of at least one NSAID; been prescribed any NSAID for three or more doses per day; or self-reported using NSAIDs at least five days a week.

NSAID use was associated with a 22 per cent increase in the risk of ED compared with men in the unexposed group (adjusted odds ratio 1.22, 95 per cent confidence interval 1.18–1.27; P<0.001).

The increase in risk was similar across all age groups; 20 per cent for those aged 45–49 years, 22 per cent for those aged 50–59 years and 23 per cent for those aged 60–69 years (P<0.001 for all age groups).

Citation: The Pharmaceutical Journal URI: 11070444

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • aspirin

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.